ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1096

CSF-specific CD8 T Cell Clonal Expansion in Neurosarcoidosis

Michael Paley1, Brandi Baker2, Steven Dunham3, Nicole Linskey3, Elisha Roberson3, David Clifford3 and Wayne Yokoyama3, 1Washington University in St. Louis, Olivette, MO, 2Washington University in St. Louis, St. Louis, MO, 3Washington University School of Medicine, St. Louis, MO

Meeting: ACR Convergence 2021

Keywords: autoimmune diseases, interferon, neurology, sarcoidosis, T-Lymphocyte

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Miscellaneous Rheumatic & Inflammatory Diseases Poster II: Clinical Features & Diagnostics (1083–1117)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Neuroinflammation is a severe manifestation of the systemic inflammatory disorders. Sarcoidosis, which leads to neurologic disease in 5-10 % of cases, has traditionally been thought to be driven by CD4 T cells. However, this model has been inferred by studies in pulmonary disease and has not been directly evaluated in the central nervous system (CNS). Here, we evaluated T and B cell clonal expansion in neurosarcoidosis to identify putative antigen-driven T or B cell responses.

Methods: We performed single-cell RNA-sequencing to obtain an unbiased gene expression survey of cerebral spinal fluid (CSF) and blood immune cells in participants with neurosarcoidosis and controls. This analysis allowed quantification, cell type identification, and transcriptional profiling of individual lymphocytes within the inflamed CNS as compared to cells in circulation, along with T cell receptor and B cell receptor sequencing to determine clonotype distribution.

Results: The plurality of CSF cells were CD4 T cells followed by CD8 T cells, with smaller and variable contributions of B cells, NK cells, and myeloid cells. Unexpectedly, B and T cell receptor sequencing revealed robust CD8 T cell clonal expansion specific to the CSF in neurosarcoidosis participants, with minimal CD4 T and B cell clonality. These CSF-specific CD8 T cells expressed higher levels of CD27 and granzyme K and lower levels of CX3CR1, granzyme B, and granulysin, consistent with reduced cytotoxicity and similar to CD8 T cells seen in uveitis and rheumatoid arthritis. Finally, a core transcriptional signature of CSF-specific CD8 T cells was predominantly composed of interferon-stimulated genes, suggestive of a potential therapeutic target.

Conclusion: These data suggest that neurosarcoidosis may be driven by clonally expanded CD8 T cells that mediate inflammation not via direct cytotoxicity but rather through pro-inflammatory cytokines. As inhibition of interferon signaling with JAK inhibitors has been efficacious in published cases of cutaneous and pulmonary sarcoidosis, this strategy may also be effective in patients with neurologic disease.


Disclosures: M. Paley, None; B. Baker, None; S. Dunham, None; N. Linskey, None; E. Roberson, None; D. Clifford, None; W. Yokoyama, None.

To cite this abstract in AMA style:

Paley M, Baker B, Dunham S, Linskey N, Roberson E, Clifford D, Yokoyama W. CSF-specific CD8 T Cell Clonal Expansion in Neurosarcoidosis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/csf-specific-cd8-t-cell-clonal-expansion-in-neurosarcoidosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/csf-specific-cd8-t-cell-clonal-expansion-in-neurosarcoidosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology